Cardiology referral (n = 75) | No referral (n = 39) | P value | |
---|---|---|---|
Year of diagnosis | 0.076 | ||
2010 | 11 (15%) | 9 (23%) | |
2011 | 24 (32%) | 15 (38%) | |
2012 | 24 (32%) | 11 (28%) | |
2013 | 16 (21%) | 4 (10%) | |
Location | 0.041 | ||
4o care centre | 20 (26%) | 4 (10%) | |
Peripheral centre | 55 (73%) | 35 (90%) | |
Age at diagnosis (y) | 57 ± 10 | 56 ± 12 | 0.714 |
T | 0.877 | ||
0 | 1 (1%) | 0 | |
1 | 27 (37%) | 14 (36%) | |
2 | 33 (45%) | 20 (51%) | |
3 | 3 (4%) | 2 (5%) | |
4 | 10 (14%) | 3 (8%) | |
N | 0.143 | ||
0 | 40 (54%) | 13 (34%) | |
1 | 24 (32%) | 19 (50%) | |
2 | 6 (8%) | 2 (5%) | |
3 | 4 (5%) | 4 (11%) | |
Mastectomy | 58 (77%) | 38 (97%) | 0.005 |
Radiation | 58 (77%) | 29 (74%) | 0.723 |
Radiation dose (Gy) | 55 (42.5,90) | 80 (0,92.5) | 0.667 |
Anthracycline dose (mg/m2) | 240 (150,240) | 240 (150,240) | 0.298 |
Pre-existing CVD | 4 (5%) | 2 (5%) | 0.963 |
CV risk factors | 39 (52%) | 18 (46%) | 0.554 |
Baseline LVEF | 61% ±6 | 60% ±7 | 0.435 |
LVEF at time of deterioration | 45% (42,47) | 47% (45,48) | 0.003 |
Symptoms of HF | 24 (32%) | 3 (8%) | 0.004 |